Massachusetts General Hospital Cancer Center strives to be a leading provider of continuing medical education to oncology professionals. Our CME offerings focus on cutting edge technologies, treatments and advancements in cancer research and care.
March 27-28, 2015
Colonnade Hotel • Boston, MA
More information regarding this course will be available soon.
2014 Chabner Colloquium: Collaboration in Cancer Drug TrialsNovember 10-11, 2014
Liberty Hotel • Boston, MA
For more information and registration, click here.
New Paradigms in Treatment-Resistant Breast Cancer
Click here to view any of 3 webinars related to the topic “New Paradigms in Treatment-Resistant Breast Cancer”. Registration is free and each webinar is CME-certified.
- Treatment Resistant, Hormone-Positive Breast Cancer: Next Steps and New Paradigms
- Triple Negative Breast Cancer: Understanding Treatment Resistance and New Treatment Options
- HER2-Positive Breast Cancer: After Trastuzumab, What’s Next?
Participate in this innovative online activity to find a thorough review of the latest clinical trial data and treatment guidelines for castration-resistant prostate cancer, as well as guidance on the mechanism of action and efficacy of newly approved and late-stage investigational treatments.
U.S. News & World Report ranks the Mass General Cancer Center in the top 10 among U.S. hospitals.
Visit TargetedCancerCare.org for more information on the latest genomic research, cancer treatments and clinical trials.
Your gift of any amount will help us in our mission to advance knowledge and to rapidly translate discovery into exceptional cancer care. Learn more about making a gift, including tribute giving and other ways to get involved.